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Fragile X syndrome, the most frequent form of inherited mental retardation, is due to the absence of Fragile X Mental
Retardation Protein (FMRP), an RNA-binding protein involved in several steps of RNA metabolism. To date, two RNA
motifs have been found to mediate FMRP/RNA interaction, the G-quartet and the ‘‘kissing complex,’’ which both induce
translational repression in the presence of FMRP. We show here a new role for FMRP as a positive modulator of
translation. FMRP specifically binds Superoxide Dismutase 1 (Sod1) mRNA with high affinity through a novel RNA motif,
SoSLIP (Sod1 mRNA Stem Loops Interacting with FMRP), which is folded as three independent stem-loop structures.
FMRP induces a structural modification of the SoSLIP motif upon its interaction with it. SoSLIP also behaves as a
translational activator whose action is potentiated by the interaction with FMRP. The absence of FMRP results in
decreased expression of Sod1. Because it has been observed that brain metabolism of FMR1 null mice is more sensitive
to oxidative stress, we propose that the deregulation of Sod1 expression may be at the basis of several traits of the
physiopathology of the Fragile X syndrome, such as anxiety, sleep troubles, and autism.
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7(1): e1000016. doi:10.1371/journal.pbio.1000016
Introduction
Fragile X Mental Retardation Protein (FMRP) is an RNA-
binding protein whose absence causes the Fragile X syn-
drome, the most frequent form of inherited mental retarda-
tion [1]. An increasing body of evidence suggests that FMRP
has a complex function, reﬂecting its involvement in the
control of hundreds of mRNA targets via its different RNA-
binding domains. Indeed, FMRP contains two heterogeneous
nuclear ribonucleoprotein (hnRNP) K-homology (KH) do-
mains and one arginine-glycine-glycine domain (RGG box)
that can mediate protein/RNA interaction [1]. Although
speciﬁcity of binding for the KH1 domain was not proved,
the KH2 domain was shown to speciﬁcally bind a category of
synthetic aptamers (‘‘kissing complex’’), a sequence-speciﬁc
element within a complex tertiary structure stabilized by
Mg
2þ [2]. However, the RGG box is able to bind G-quartet
RNA with high afﬁnity [3,4]. This structure is present in
several FMRP mRNA targets, such as Fragile X Mental
Retardation 1 (FMR1), Microtubules Associated Protein 1B
(MAP1B), and PP2Ac Protein Phosphatase 2A catalytic subunit
(PP2Ac) [3–5]. FMRP is able to shuttle between nucleus and
cytoplasm, where it is mostly associated with polyribosomes,
suggesting an implication in translational control [1]. In
neurons, FMRP is also involved in RNA trafﬁcking along
dendrites and axons, being a component of RNA granules
and functioning as a molecular adaptor between these
complexes and the neurospeciﬁc KIF3C kinesin [6,7]. More-
over, after traveling along dendrites, FMRP associates with
polyribosomes localized at the synapse to participate in the
translational control of proteins synthesized in this compart-
ment [8].
Taking into consideration the results obtained from
different laboratories, several mechanisms of action of FMRP
have been proposed suggesting: (i) polysomal stalling for
MAP1B mRNA expression regulation [9]; (ii) retention of
mRNAs in translationally inactive messenger RNPs (mRNPs)
via its interaction with the kissing complex motif [2]; (iii)
inhibition of translation preventing ribosome scanning via a
G-quartet structure localized in the 59 UTR of a target mRNA,
as for the PP2Ac mRNA [5]. Moreover, the ability of FMRP to
stabilize the Post Synaptic Density 95 (PSD95)m R N A ,b y
interacting with its 39 UTR, was recently reported [10]. Here
we show that FMRP interacts with the Superoxide Dismutase 1
(Sod1) mRNA with high speciﬁcity and afﬁnity via a novel
RNA structure that we named SoSLIP (Sod1 Stem Loop
Interacting with FMRP). SoSLIP is organized in a triple stem-
loop structure and acts as an FMRP-dependent translational
enhancer and as a mild internal ribosome binding site (IRES)
in an FMRP-independent manner. The characterization of
this novel RNA motif interacting with FMRP sheds new light
on the ability of this protein to bind RNA and to improve the
translation of SoSLIP-containing mRNAs. Our results, taken
together with other recent ﬁndings [11,12], suggest that the
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PLoS BIOLOGYderegulation of Sod1 expression may have an important role
in the pathogenetic mechanism of Fragile X syndrome.
Results
FMRP Binds Sod1 mRNA with High Affinity via Its C-
Terminal Domain
With the goal to ﬁnd novel mRNA structures speciﬁcally
recognized by FMRP, we performed a systematic analysis of
known FMRP mRNA targets, focusing on those that have
been shown to interact in vivo with FMRP by the antibody-
positioned RNA ampliﬁcation (APRA) technique [13]. First,
we excluded the presence of already known structures bound
by FMRP in these mRNA targets by screening their capacity
to bind a recombinant FMRP in the presence of Na
þ,K
þ,o r
Mg
2þ. Indeed, K
þ ions stabilize the G-quartet RNA structure,
leading to a robust interaction with FMRP [4], whereas Mg
2þ
favors FMRP/kissing complex RNA interaction [2]. This
analysis resulted in the characterization of FMRP/Sod1
interaction, which takes place in the presence of K
þ (Figure
1A) and is not affected by the presence of Na
þ (Figure 1B),
whereas, as expected, Na
þ affects the binding of FMRP to the
N19 sequence that contains the G-quartet present in FMR1
mRNA (nucleotide (nt) 1470–1496) [4]. Moreover, to deﬁnitely
exclude the presence of a G-quartet structure in Sod1 mRNA,
we performed a reverse transcriptase (RT) elongation
reaction assay, as previously described [4]. In the presence
of K
þ, G-quartet RNA is very stable, blocking RT progression
at its 39 edge and resulting in a truncated transcription
product. Conversely, in the presence of Na
þ, G-quartet
structures are destabilized, and the RT can proceed to the
end of the RNA [4] . The RT elongation test on Sod1 mRNA
did not reveal any K
þ-dependent stop of the polymerase
(Figure S1), demonstrating that Sod1 mRNA is not able to
form a G-quartet structure. Moreover, FMRP/Sod1 interaction
was not dependent on the presence of Mg
2þ, which is
necessary to stabilize the ‘‘kissing complex’’ RNA structure
(unpublished data) [2]. Taken together, these ﬁndings suggest
that FMRP binds to Sod1 mRNA via a novel sequence/
structure. We continued the characterization of the FMRP/
Sod1 mRNA interaction by testing the ability of Sod1 mRNA to
c o m p e t ef o rt h eb i n d i n go ft h eF M R P / G - q u a r t e tR N A
structure [4]. Indeed, 5 nM unlabeled Sod1 mRNA competed
very efﬁciently (65%) with the previously identiﬁed N19
FMRP binding site in a gel-shift assay, whereas a negative
control, N8 RNA (corresponding to nt 1–654 of FMR1 mRNA
that does not contain the G-quartet), was not able to compete
for the same interaction (Figure 1C). To precisely deﬁne the
region of Sod1 mRNA interacting with FMRP, we generated
three different constructs from Sod1 encompassing its full-
length cDNA: its 59 UTR and a portion of its coding region
(Sod1–59 region), a central part of the coding region (Sod1-mid
region), and a fragment overlapping the end of the coding
region and the 39 UTR (Sod1–39 region) (Figure 2A). RNA
sequences corresponding to each fragment were produced
and tested for their ability to interact with FMRP. Only the
Sod1–59 region (spanning nt  70 to þ148 of Sod1 mRNA)
competed with N19 binding to FMRP with the same afﬁnity as
the full-length Sod1 mRNA (3 nM concentrations of both cold
probes compete for 50% of FMRP/N19 binding) (Figure 2B).
To identify the sequence of Sod1 mRNA that is recognized
and bound by FMRP, we employed a site boundary
determination method [4]. In this experiment, the 39-o r5 9-
Figure 1. FMRP Specifically Binds Sod1 mRNA
FMRP binding to Sod1 mRNA is not dependent on K
þ. Labeled G-quartet
RNA (N19) or Sod1 full-length mRNA were incubated with increasing
amounts of recombinant His-FMRP in the presence of K
þ(A) or Na
þ(B).
FMRP/Sod1 binding was not affected by ionic conditions, whereas, as
expected, the presence of Na
þ affected FMRP binding to N19.
(C) Gel-shift experiments were performed using a
32P-labeled N19 probe
incubated with 0.1 pmol of recombinant His-tagged FMRP in the
presence of increasing amounts of unlabeled competitors, ranging from
10
 9 to 10
 7M [lanes 3–5 (N19), lanes 6–8 (Sod1), lanes 9–11 (N8)]. Lane 1,
no protein control; lane 2, no competitor control. Note that both N19
(positive control) and Sod1 compete equally well for binding to FMRP,
whereas N8 (negative control) only competes at high concentrations
(nonspecific binding). All data obtained in these experiments are listed in
Table S2.
doi:10.1371/journal.pbio.1000016.g001
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FMRP Modulates Sod1 mRNA Translation
Author Summary
The most common form of inherited mental retardation, Fragile X
syndrome, is caused by the absence of the Fragile X Mental
Retardation Protein (FMRP), which can bind mRNA. In mice devoid
of FMRP, several hundreds of mRNAs with altered expression and
localization have been reported. The impact of these abnormalities
is particularly important in the brain, where the absence of FMRP
affects the structure and function of connections between neurons,
resulting in reduced cognitive abilities. In recent years, scientists
studying Fragile X syndrome have focused on identifying the RNAs
that are specifically bound by FMRP. We and others have identified
two specific RNA structures bound by FMRP/RNA. Importantly, when
FMRP binds these structures, the translation of the RNA into its
protein product is inhibited. In this new study we have identified a
third FMRP-binding RNA structure that is found in the mRNA that
encodes superoxide dismutase, an oxidative-stress-mitigating en-
zyme. Most significantly, FMRP enhances translation of the super-
oxide dismutase mRNA when it interacts with the structure. These
findings suggest that absence of FMRP might result in reduced
levels of superoxide dismutase, which in turn leads to increased
oxidative stress in the brain. Interestingly, oxidative stress in the
brain has already been linked to anxiety, sleeping difficulties, and
autism, all of which typically affect individuals with Fragile X
syndrome.end-labeled Sod1–59 RNA was treated by mild alkaline
hydrolysis in order to generate a pool of smaller fragments.
The RNA fragments retaining the capacity to bind FMRP
were selected on immobilized glutathione-S-transferase
(GST)-FMRP, as previously described [4]. Bound RNAs were
analyzed by electrophoresis on a denaturing polyacrylamide
gel (not shown). The border positions were at 30 andþ34 for
39- and 59-end-labeled fragments, respectively. This technique
allowed us to deﬁne a 64-base region spanning both sides of
the Sod1 AUG start codon that is protected by FMRP. We
subcloned this sequence, and we synthesized its correspond-
ing RNA, generating the Sod1–64 RNA. This RNA was bound
speciﬁcally by FMRP, because it was able to compete for the
FMRP/Sod1 full-length mRNA interaction (Figure 2C). Inter-
estingly, the FMRP/Sod1–64 interaction is competed for by the
N19 G-quartet-containing RNA to the same extent (unpub-
lished data).
To assess which portion of FMRP was able to interact with
Sod1 mRNA, we produced protein fragments of the different
RNA-binding domains of FMRP (e.g., KH1, KH2, and RGG-
box-containing C-terminal domains) as recombinant proteins
in a bacterial system [14], and we used them in binding assays
with the Sod1–64 RNA. Interestingly, we observed that Sod1–
64 RNA interacts only with the C-terminal domain of FMRP
encompassing the RGG box (Figure 2D) and was not able to
interact with any of the KH domains, even at high protein
concentrations (Figure 2D). As described previously, the same
C-terminal domain was also able to bind the G-quartet RNA
structure [3].
To assess whether Sod1–64 RNA binds FMRP in the same
ionic conditions as the full-length Sod1 mRNA, we performed
a binding assay in the presence of either K
þ or Na
þ. As shown
in Figure 2E, no differences were observed in the protein/
RNA interaction under both conditions.
In addition, we tested the abilities of different Fragile X
Mental Retardation Protein (FXR1P) isoforms to bind Sod1,a s
we have previously done for G-quartet RNA structures [15].
We used FXR1P Isoe (only expressed in muscle) and Isoa and
Isod (highly expressed in brain but not in muscle) in a ﬁlter
binding assay using Sod1 as a probe. We observed that all
FXR1P isoforms bind Sod1 mRNA with lower afﬁnity
compared with that of FMRP. However, substantial differ-
ences exist among the three isoforms. Indeed, the afﬁnity of
Isoe for Sod1 is quite high, because approximately 20 nM
competitor RNA is able to displace 50% of Sod1 mRNA from
Isoe. Conversely, the afﬁnities of Isoa and Isod are very low.
These ﬁndings are shown in Figure S2.
Structure of the Sod1 mRNA Region Interacting with FMRP
To unravel the mechanism of action of the FMRP/Sod1–64
interaction in translational control, we decided to determine
Sod1–64 RNA structure in the absence and in the presence of
FMRP. To determine the secondary structure of Sod1–64
RNA, we probed the structure of this 64-base region in
solution, using a panel of chemical and enzymatic modiﬁca-
tions, as described [16]. This technique is based on the
reactivity of RNA molecules toward chemicals or enzymes
that modify or cleave speciﬁc atomic positions in RNA. The
probing experiments were performed using unlabeled or
radioactively end-labeled in vitro transcribed RNAs (Sod1–59
region), which were subjected to random digestion with
RNases T1, T2, and V1 or chemical modiﬁcations with
dimethyl sulfate (DMS) and a carbodiimide derivative
(CMCT). RNase T1 cuts after guanine residues in single-
stranded regions, RNase T2 cleaves after all single-stranded
residues, but preferentially after adenines, whereas RNase V1
cuts at double-stranded or stacked bases. DMS alkylates the
N1 position of adenines and the N3 position of cytosines,
whereas CMCT modiﬁes the N1 position of guanines and the
N3 position of uridines. The sites of cleavage or modiﬁcation
were then identiﬁed by primer extension with reverse
Figure 2. FMRP Binds a 64 Base Fragment of Sod1 mRNA via Its C-
Terminal Region
(A) Schematic representation of Sod1 mRNA and its fragments subcloned
from full-length cDNA and used to map the binding domain of FMRP on
Sod1 mRNA.
(B) Binding specificity of FMRP to Sod1–59 region. Filter binding assay
using FMRP and
32P-labeled N19. The competition was performed using
various regions of unlabeled Sod1 mRNA: Sod1–59 region, Sod1-mid
region, Sod1–39 region, and N19 itself. The graph shows the fraction of
bound labeled N19 RNA plotted versus unlabeled competitor RNA
concentration.
(C) Binding specificity of FMRP to Sod1–64 fragment. Filter binding assay
using FMRP and
32P-labeled Sod1 mRNA. Competition was performed
with different unlabeled mRNA fragments, as indicated in the figure The
Sod1–64 RNA fragment shows a competition profile similar to that of
Sod1 full-length mRNA.
(D) Filter binding assays using various recombinant RNA-binding
domains of FMRP. KH1, KH2, and the C-terminal domain containing
the RGG box and
32P-labeled RNAs reveal that the FMRP C-terminal
domain displays equal affinity for Sod1 mRNA or G-quartet (N19
fragment), whereas the two KH domains are not able to bind Sod1
mRNA.
(E) Filter binding assay using increasing amounts of recombinant His-
FMRP and
32P-labeled RNA fragments in the presence of K
þ or Na
þ.
FMRP/Sod1–64 RNA binding is not dependent on ionic conditions,
excluding the presence of a G-quartet-forming structure RNA. All data
are listed in Table S2.
doi:10.1371/journal.pbio.1000016.g002
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FMRP Modulates Sod1 mRNA Translationtranscriptase, using a radiolabeled primer complementary to
the Sod1-59 region. Analysis of the resulting cDNAs was
performed on sequencing polyacrylamide gels that were run
together with the corresponding RNA sequencing ladder to
allow identiﬁcation of the modiﬁed residues (Figure S3). A
secondary structure model was further derived by combining
experimental data and free energy data calculated using the
mFOLD program (http://helix.nih.gov/apps/bioinfo/mfold.
html). The structure of Sod1–64 RNA appears as a succession
of three independent stem-loop structures that are separated
by short single-stranded regions (Figure 3A). Sod1–64 appears
strongly conserved at the sequence and structure level also in
rat and human (Figure 3B and 3C). We called this FMRP-
interacting structure SoSLIP.
We then analyzed the SoSLIP structure by RNA protection
after incubation with FMRP. SoSLIP RNA was treated by V1
nuclease, DMS, and Pb
2þ in the absence or in the presence of
increasing amounts of recombinant FMRP. The modiﬁed
RNA was reverse-transcribed using the radiolabeled primer
IV, and the obtained products were separated by PAGE
(Figure 4A). Protections and increases of reactivity were
found within a region extending from nucleotides 10 toþ34
(Figure 4B). Interestingly, lead, a probe speciﬁc for unpaired
nucleotides, ﬂexible regions, and protein binding sites, with
no base speciﬁcity, revealed protections over this whole area.
Because of their extent, these protections indicate a
combination of both direct protection from the protein
and strengthening of the structure. Noticeably, the hyper-
Figure 3. Secondary Structure of the SoSLIP RNA Fragment
(A) RNA secondary structure model of the mouse Sod1–64 RNA fragment (SoSLIP) showing results from enzymatic cleavage and chemical modification
experiments. White and black arrows represent moderate and strong RNase T1 cleavage sites, respectively. White and black triangles represent
moderate and strong RNase V1 cleavage sites, respectively. Symbols used to indicate the reactivity of different drugs or nucleases are shown in the
figure; ‘‘X’’ represents RT pauses.
(B) Alignment of SoSLIP sequence in mouse, rat, and human.
(C) Conservation of the SoSLIP RNA secondary structure in rat and human.
doi:10.1371/journal.pbio.1000016.g003
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FMRP Modulates Sod1 mRNA Translationreactive positions þ26 and þ27 in L3 were particularly
protected by the protein. A modiﬁcation of the SoSLIP
structure is further indicated by the increases of reactivity
observed with V1 cleavages (for example, the (A) base of Sod1
starting codon AUG and its preceding base (C), as well as the
second stem and the more 3’ part) (Figure 4B). In conclusion,
these data indicate that FMRP protects the RNA particularly
at the level of the L2 and L3 loops and induces conforma-
tional changes of the L2 and L3 stems, with the possible
exposure of several nucleotides, and in particular the AUG
sequence in the L2 stem, in the presence of the protein.
Role of FMRP in Stability and Translatability of Sod1 mRNA
We investigated the impact that the absence of FMRP has
on the stability and translatability of Sod1 mRNA. To explore
Sod1 mRNA decay, we blocked transcription in primary
cultured hippocampal neurons and in STEK cell lines by
actinomycin D treatment. We did not observe any signiﬁcant
difference in Sod1 mRNA levels of neurons obtained from
wild-type or of Fmr1 null mice (Figure 5A) or ﬁbroblasts
expressing or not expressing a FMR1 transgene, even after 12
h of actinomycin D treatment (Figure 5B). Then, we analyzed
Figure 4. Chemical and Enzymatic Probing of the SoSLIP and Its Resulting Secondary Structure in the Presence and in the Absence of FMRP
(A) PAGE gel showing the running of retrotranscribed SoSLIP RNA after treatment with RNase V1 (left), DMS (middle), and lead (right). ‘‘C’’ indicates the
lane where SoSLIP was untreated, lane 1 is the treated RNA, and lanes 2 and 3 represent the SoSLIP RNA after incubation with an increasing amount of
FMRP before being treated as described. The positions of nucleotides are indicated together with the region corresponding to the second (L2) and third
(L3) loops.
(B) RNA secondary structure model of SoSLIP showing results from enzymatic cleavage and chemical modification experiments in the presence of FMRP.
The symbols indicating reactivity toward V1, DMS, or lead are shown on the right. The two symbols þ and – were used to indicate an increased or
decreased reactivity, respectively, upon the interaction with FMRP.
doi:10.1371/journal.pbio.1000016.g004
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FMRP Modulates Sod1 mRNA Translationthe level of Sod1 expression in cytoplasmic RNA extracts from
STEK cells [5], total brain, hippocampus, and cerebellum of
mice expressing or not expressing the Fmr1 gene. With
quantitative (q) RT-PCR, the amount of Sod1 mRNA was
found to be equivalent in both wild-type and Fmr1 knockout
cells and tissues when normalized to the level of Hprt mRNA
(Figure 5C). All of these data excluded the possibility that
FMRP would regulate the stability of Sod1 mRNA. We then
investigated the role of FMRP in Sod1 mRNA translatability.
FMRP being a well-known polyribosome-associated protein
in brain [2,17–19] and all tissues and cell lines analyzed
[20,21], we studied the distribution of Sod1 mRNA in
polyribosomes derived from extracts of STEK cells expressing
or not expressing a FMR1 transgene and from brain extracts
of wild-type and Fmr1 null mice. We used the polyribosome
puriﬁcation procedure previously described [19], because this
method is based on the concentration of polyribosomal
franctions, avoiding contamination of light mRNP. We
evaluated the Sod1 mRNA level by qRT-PCR using Hprt
mRNA as an internal control. In the absence of FMRP, we
observed a decreased level of Sod1 mRNA in polyribosome
fractions (medium and heavy) obtained from ﬁbroblasts
(Figure 5D), as well as in the corresponding polyribosomal
fractions obtained from total brain (Figure 5E). Indeed, as we
have shown in Figure 5D and 5E, the amount of Sod1 mRNA
associated with polyribosomes is dependent on the amount of
FMRP, because a reduced association (statistically signiﬁcant)
is observed in medium and heavy fractions where the amount
of FMRP is most abundant, and nonsigniﬁcant differences are
observed in the light fractions where the amount of FMRP is
less abundant. These results suggest that the absence of FMRP
plays a key role in Sod1 mRNA incorporation in the
translating machinery.
Figure 5. Stability and Translatability of Sod1 mRNA
(A) Primary cultured hippocampal neurons derived from Fmr1 knockout or wild-type mice were incubated with 5 lM actinomycin D. Total RNA was
extracted at different times (2, 4, 6, and 12 h) after the treatment, and Sod1 mRNA was quantified by qRT-PCR as described [37]. All results are listed in
Table S2.
(B) STEK cells expressing or not expressing FMRP were incubated with 5 lM actinomycin D. Total RNA was extracted at different times (2, 4, 6, and 12 h)
after the treatment, and Sod1 mRNA was quantified by qRT-PCR as described [37]. Values are listed in Table S2.
(C) Cytoplasmic RNA was extracted from cells and mice tissues expressing or not expressing FMRP. The Sod1 mRNA level was normalized by the Hprt
mRNA level by applying the formula: Ct Sod1/Ct Hprt. As shown in the diagram, the Sod1 mRNA levels were not affected by the absence of FMRP, and
no statistically significant differences were observed for Sod1 mRNA levels in tissues and cell lines expressing or not expressing FMRP. Results are
presented as the mean 6 SEM.
(D) Polyribosome association of Sod1 mRNA in brain obtained from wild-type and Fmr1 null mice. The UV profile of a sucrose density gradient is shown,
and the 80S monosome peak is indicated. RNA purified from fractions corresponding to 80S and light-, medium-, and heavy-sedimenting
polyribosomes were pooled, and the Sod1 mRNA levels in each pool were determined by qRT-PCR by applying the formula: Ct Sod1/Ct Hprt. Sod1 mRNA
is less associated with medium and heavy polyribosomes in the absence of FMRP. Results are presented as the mean 6 SEM (Student’s t-test, **p , 0.01
for medium polyribosomes) (Student’s t-test, *p , 0.05 for heavy polyribosomes). No statistically significant differences were observed for light
polyribosomes.
(E) Polyribosome association of Sod1 mRNA in STEK cell lines expressing or not expressing FMR1. The UV profile of a sucrose density gradient is shown,
and the 80S monosome peak is indicated. RNA purified from fractions corresponding to 80S and light-, medium-, and heavy-sedimenting
polyribosomes were pooled, and the Sod1 mRNA level in each pool was quantified as described in (D). Sod1 mRNA is reduced in medium and heavy
polyribosomes in the absence of FMRP. Results are presented as the mean 6 SEM (Student’s t-test, **p , 0.01 for medium polyribosomes) (Student’s t-
test, *p , 0.05 for heavy polyribosomes). No statistically significant differences were observed for light polyribosomes.
doi:10.1371/journal.pbio.1000016.g005
PLoS Biology | www.plosbiology.org January 2009 | Volume 7 | Issue 1 | e1000016 0138
FMRP Modulates Sod1 mRNA TranslationSod1 Expression Is Impaired in Fmr1 Null Mice
To assess whether the reduction of the association of Sod1
mRNA with polyribosomes impairs the expression of the
Sod1 protein in the absence of FMRP, we analyzed total
protein extracts obtained from STEK cells expressing or not
expressing a FMR1 transgene [5], and we observed that Sod1
protein expression is reduced by approximately 40% in Fmr1
null cells, as compared to that of cells expressing FMRP and
after normalization of its expression to that of b-tubulin
(Figure 6A). Similarly, we observed a signiﬁcant decrease in
Sod1 level in total protein extracts from whole brain (Figure
6B), hippocampus (Figure 6C), and cerebellum (Figure 6D) of
12-day-old Fmr1 null mice, as compared to those of wild-type
littermates. Sod1 levels were also reduced in Fmr1 null mice
embryos at 10 days post coitum (10dpc) (Figure 6E). We
therefore concluded that Sod1 levels are directly correlated
with the reduced association of its mRNA on medium- and
heavy-sedimenting polyribosomes in Fmr1 null mice, suggest-
ing that FMRP promotes the association of Sod1 mRNA to
actively translating polyribosomes.
Role of the FMRP/SoSLIP Complex in Translation
To conﬁrm the positive role of FMRP in translational
modulation of Sod1 expression by the interaction with the
SoSLIP RNA structure, we cloned this sequence upstream of
the luciferase gene in the pcDNA3.1 zeo vector (Luc) to
evaluate the effect of the pr e s e n c eo fS o S L I Po nt h e
expression of a reporter protein. We transfected primary
cultured hippocampal neurons with the SoSLIP-luciferase
vector (SoSLIP-Luc) or with the Luc vector, and we tested
luciferase activity, showing on average an 8-fold increase
when SoSLIP is placed upstream of the reporter (Figure 7A).
A similar result was obtained in FMR1-expressing STEK cells
(Figure 7A). Analysis of luciferase mRNA levels tested by qRT-
PCR revealed that the presence of SoSLIP did not affect the
mRNA expression level or stability of the dowstream reporter
gene (Figure S4A and S4B). These results indicate that SoSLIP
behaves per se as a translational activator in both cell types.
We then transfected the same plasmid in primary hippo-
campal neurons obtained from normal and Fmr1 null mice
and in STEK cells expressing or not expressing the FMR1
transgene. Indeed, in the absence of FMRP, luciferase activity
resulted in a 2-fold reduction as compared with that in the
presence of FMRP (wild-type condition) (Figure 7B). These
data suggest that the presence of FMRP potentiates the ability
of the SoSLIP sequence to positively modulate the expression
of a downstream coding sequence independently of the
cellular type. In addition, our ﬁndings are compatible with
the notion that FMRP’s roles in translation might be positive
or negative as discussed [1,13]. To test the functional
importance of SoSLIP stem loops, we disrupted each of the
three stem loops by site-directed mutagenesis (Figure 7C).
Using a ﬁlter binding assay, we then tested the ability of each
mutant to compete for the binding of the FMRP/SoSLIP
interaction. As shown in Figure 7D, the SL1 mutant is able to
fully compete for SoSLIP binding (4 nM cold SL1 probe
competes for 50% of wild-type SoSLIP), indicating that the
disruption of SL1 does not affect FMRP/SoSLIP interaction.
Conversely, the two SL2 and SL3 mutants poorly compete for
SoSLIP binding to FMRP (60 nM concentrations of both cold
probes compete for 50% of SoSLIP). The disruption of these
two stem loops reduces their afﬁnity for FMRP binding
(Figure 7D) but did not abolish this binding, as suggested by
comparing with the competition of an RNA sequence not
bound by FMRP (Figure 7D, 39 UTR Sod1 RNA as the cold
competitor). All three mutations affect the SoSLIP transla-
tional enhancer properties, reducing the level of luciferase
activity (Figure 7E), if compared with the luciferase activity of
the SoSLIP-Luc construct. Indeed, the activities of SL1-Luc,
SL2-Luc, and SL3-Luc are reduced by 80%, 50%, and 60%,
respectively, if compared with SoSLIP-Luc activity when
these constructs have been transfected in cells expressing
FMRP. The activities of SL1-Luc, SL2-Luc, and SL3-Luc are
also reduced (62%, 44%, and 50%, respectively), if compared
with SoSLIP-Luc activity when these constructs have been
Figure 6. Decreased Levels of Sod1 Protein in Fmr1 Null Cells, Brain, and
Embryos
Western blot analysis of one FMR1
þ STEK clone (where FMR1 was
reintroduced) and one STEK FMR1 null clone. The results shown on the
left are representative of the different clonal cell lines. On the right,
corresponding densitometric analyses show a significant decrease of
Sod1 expression, after comparing five wild-type rescued clones and five
FMR1 knockout clones. Three independent experiments were quantified.
Results presented as the mean 6 SEM (Student’s t-test, *p , 0.05) are
the average of Sod1 levels normalized for b-tubulin expression The same
analysis described in (A) was applied for mouse total brain (B), mouse
hippocampus (C), mouse cerebellum (B) and mouse 10dpc embryo
extracts (E). Densitometric analysis showing a significant decrease in
Sod1 expression. Three independent experiments were quantified using
eight wild-type and eight Fmr1 null mice. Results presented as the mean
6 SEM (Student’s t-test, **p , 0.01) are the average of Sod1 levels
normalized for b-tubulin expression.
doi:10.1371/journal.pbio.1000016.g006
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FMRP Modulates Sod1 mRNA Translationtransfected in cells not expressing FMRP. Furthermore, in
Fmr1 knockout cells, the two SL2 and SL3 mutants have a
reduced translational enhancing activity if compared with
their activity in wild-type cells (Figure 7E) (40% and 33%
reduced activity, respectively), conﬁrming the data obtained
by the in vitro binding. Surprisingly, the absence of FMRP
does not modify the impact of the SL1 mutant on luciferase
activity (Figure 7E), suggesting that also the SL1 integrity is
necessary for the correct function of FMRP. To conﬁrm that
the effect of the mutants was only affecting translation
efﬁciency, the expression and the stability of the mRNAs of
all three SoSLIP mutants were tested, and no differences were
observed with the wild-type mRNA, in the presence or in the
absence of FMRP (Figure S4A–S4C).
These results suggest a complex translational regulation of
Sod1 mRNA via the SoSLIP structure.
SoSLIP Acts as an IRES-like Element in an FMRP-
Independent Manner
Due to its effects on translation, we asked then whether
SoSLIP may act as an IRES. For this purpose, we used the
pPRIG-HA-red bicistronic vector, where Discosoma sp. red
ﬂuorescent protein (DsRed) and enhanced green ﬂuorescent
protein (eGFP) are under the control of the same promoter.
The DsRed is translated in a cap-dependent manner, whereas
eGFP is translated only if an IRES sequence is cloned in front
of it, as described [22]. We removed the IRES sequence
(pPRIGempty), and we cloned the SoSLIP sequence between
the DsRed and the eGFP cDNAs (SoSLI-PRIG) (Figure 8A).
After 48 h of transfection, HeLa cells were analyzed by
ﬂuorescent-activated cell sorting (FACS), and the eGFP
intensity was quantiﬁed for 200,000 cells expressing DsRed
at a constant intensity. As shown in Figure 8B, we did not
Figure 7. Impact of SoSLIP on Translational Regulation
(A) Effect of SoSLIP sequence upon luciferase expression: luciferase activities of Luc or SoSLIP-Luc vectors in primary neurons and STEK cells. Three
independent experiments with three replicates, done in triplicate, for each transfection were quantified. For each transfection, firefly(F) luciferase (luc)
activity was normalized by Renilla (R) luciferase (luc) activity. Results are presented as the mean 6 SEM (Student’s t-test, **p , 0.01).
(B) Activity of SoSLIP-Luc in neurons and STEK cells expressing or not expressing FMRP. Three independent experiments in triplicate for each
transfection were quantified. For each transfection, Fluc activity was normalized by Rluc activity. Results presented here represent the mean 6 SEM of
the ratio of SoSLIP-Luc to Luc activities (Student’s t-test, **p , 0.01).
(C) Schematic representation of the wild-type SoSLIP sequence and its three mutants (SL1, SL2, and SL3).
(D) Binding affinity of FMRP to wild-type SoSLIP and SL1, SL2, and SL3 mutants. Filter binding assay using radiolabeled SoSLIP and unlabeled cold RNA
competitors SoSLIP, Sod1–39 region, SL1, SL2, and SL3. All of the results obtained in the filter binding assay are listed in Table S2.
(E) Effect of SoSLIP mutants (SL1-Luc, SL2-Luc, and SL3-Luc) on luciferase expression in STEK cells expressing or not expressing FMRP. Three
independent experiments in triplicate for each transfection were quantified. For each transfection, Fluc activity was normalized to Rluc activity. Results
presented here represent the mean of the ratio of SoSLIP-Luc to Luc, SL1-Luc to Luc, SL2-Luc to Luc, and SL3-Luc to Luc. The luciferase activities of the
three mutants were compared to wild-type SoSLIP luciferase activity in cells expressing FMRP, and the difference was significant in all cases (Student’s t-
test, **p , 0.01). The same analysis was repeated in cells not expressing FMRP, and the difference was significant in all cases (Student’s t-test, ##p ,
0.01). The luciferase activity of each mutant in cells expressing or not expressing FMRP was evaluated. For mutants SL2 and SL3, the reduction of
lucferase activity observed in Fmr1 null cells was statistically significant. These results are presented as the mean 6 SEM (Student’s t-test, 88p , 0.01).
For mutant SL1, no significant reduction of luciferase activity was observed in cells not expressing FMRP compared with cells expressing FMRP. These
results are presented as the mean 6 SEM. RLU, relative luciferase units.
doi:10.1371/journal.pbio.1000016.g007
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pPRIGempty, conﬁrming that eGFP is not expressed in the
absence of an upstream IRES sequence. Conversely, when
SoSLIP is placed upstream of eGFP cDNA, green ﬂuorescence
becomes readily detectable. However, in this case, the mean
eGFP ﬂuorescence intensity was 5.4-fold less than that when
using the strong viral IRES in pPRIG-HA (250 and 1,400
arbitrary units (AUs), respectively). The same result was
observed following transfection of the neuroblastoma NG108
cell line, neurons, COS cells, and STEK cells expressing FMR1
(unpublished data). No differences were observed in the
intensity level of GFP ﬂuorescence from the SoSLI-PRIG
vector in cells expressing or not expressing FMRP, suggesting
that this protein is not required for the mild IRES-like
activity of SoSLIP (Figure 8C). Even if FMRP cannot be
considered as an IRES translational activating factor, the
observation that SoSLIP may act as an IRES-like sequence is
important to understand the role of SoSLIP in translational
control. To conﬁrm this result, we produced mRNAs
encoding luciferase and SoSLIP-Luc carrying or not carrying
the cap modiﬁcation, and we translated in vitro equal
amounts of each mRNA in rabbit reticulocyte lysate (RRL)
and in wheat germ extract (WGE). As expected, luciferase
mRNA is translated with higher efﬁciency when the mRNA is
capped (Figure 8D). SoSLIP-Luc is translated in a cap-
independent manner with efﬁciency comparable to that
obtained in the cap-dependent manner (Figure 8E). The same
result was obtained for the translation of Sod1 mRNA in the
capped and not capped versions (Figure 8F). No differences
were observed using either the RRL or the WGE systems.
Discussion
The primary function of FMRP resides in its ability to bind
mRNAs. Despite the importance of this function, the RNA
binding speciﬁcity of FMRP is not completely understood
[23]. To date, only a single structure, the G-quartet, was found
to mediate the speciﬁc interaction of FMRP with several of its
target mRNAs [3–5,24]. A synthetic RNA with a speciﬁc
structure, called the ‘‘kissing complex,’’ binds FMRP with high
afﬁnity but has not been found in any naturally occurring
mRNA that is a target of FMRP [2,24]. The G-rich 39 UTR of
PSD95 mRNA has been reported to interact with FMRP, and
the authors claimed that this interaction happens via a novel
motif [10]. The structure of this motif has not been deﬁned,
but a sequence highly similar (95%) to the G-quartet
consensus previously determined [3] is present in the 39
UTR of PSD95, strongly suggesting the presence of a G-
quartet in PSD95 mRNA [25]. Other mechanisms depending
on the interaction of FMRP with noncoding mRNAs are
controversial [26]. In conclusion, the speciﬁc sequence/region
mediating the interaction of most putative mRNA targets
with FMRP has not been experimentally deﬁned. It is thought
that elucidating the functional signiﬁcance of the FMRP/RNA
interaction is a critical step to understand the molecular
bases of Fragile X syndrome. On the basis of conclusions from
several laboratories, it has been considered that FMRP
behaves exclusively as a translational repressor [4,27]. Recent
studies have proposed a more complex function for FMRP,
possibly depending on the speciﬁc binding of its target RNAs,
on conformational changes in its structure, or on the
inﬂuence of FMRP-interacting proteins [1,3,13,15]. Further-
Figure 8. SoSLIP Acts as an FMRP-Independent IRES-like Element
(A) Diagram of different constructs containing both DsRed and eGFP.
These plasmids were modified by insertion of either a linker sequence
(pPRIG-empty), the SoSLIP sequence (SoSLI-PRIG), or a characterized IRES
(pPRIG-HA-red).
(B) Histogram showing eGFP intensity (green) in a FACScan analysis on
HeLa cells transfected with pPRIGempty, SoSLI-PRIG, or pPRIG-HA-red
vectors. Two-hundred thousand cells positive for DsRed expression were
analyzed for each transfection, and three independent experiments were
quantified. The mean intensity of eGFP was calculated by the instrument
software. Statistical analysis shows a significant difference between the
mean intensity of GFP obtained by the pPRIGempty vector and that
obtained by the SoSLI-PRIG vector (Student’s t-test, **p , 0.01).
(C) The same analysis described in (B) was repeated in STEK cells
expressing or not expressing the FMR1 transgene. Statistical analysis
does not show a significant difference between the mean intensity of
GFP in cells expressing or not expressing FMRP. Results are presented as
the mean 6 SEM.
(D) In vitro translated capped and noncapped mRNA luciferase (Luc
vector) in WGE. The relative intensity of each band was evaluated by
densitometric analysis, and the values obtained are represented in the
histograms. Four different experiments were quantified, and results are
presented as the mean 6 SEM (Student’s t-test, ***p , 0.001).
(E) The same experiment described in (D) was repeated for the in vitro
translation of SoSLIP-Luc mRNA. Four different experiments were
evaluated, and no statistically significant differences were observed.
(F) The same experiment described in (D) was repeated for the in vitro
translation of Sod1 mRNA. Four different experiments were evaluated,
and no statistically significant differences were observed.
As in (D), in (E) and (F), results are presented as the mean 6 SEM.
doi:10.1371/journal.pbio.1000016.g008
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FMRP Modulates Sod1 mRNA Translationmore, a related member of the FXR family, FXR1P, was
reported to function as a translational activator when
associated with the AU-rich element present in the 39 UTR
of TNFa mRNA in response to serum starvation [28].
In this study, we deﬁne a new function of FMRP by
dissecting the mechanism of binding of FMRP to the Sod1
mRNA that was previously identiﬁed as an in vivo target of
FMRP in cultured primary neurons [13]. Here we show that
FMRP recognizes Sod1 mRNA via a novel motif, the SoSLIP,
organized in three stem loops separated by short sequences.
In the absence of FMRP, Sod1 mRNA present in polyribo-
somes is reduced, and Sod1 protein is less expressed in brains
and cell lines from FMR1 knockout mice, suggesting that
Sod1 expression is positively modulated by the interaction
between SoSLIP and FMRP. We have shown that the presence
of FMRP protects the L2 and L3 loops of the SoSLIP
structure. It is clear from our analyses that this interaction
promotes structural modiﬁcations around the AUG start
codon of Sod1 mRNA and the more 39 end portion of SoSLIP.
These structural modiﬁcations apparently favor translation.
SoSLIP is able to positively modulate the expression of a
reporter gene, whose translation is also signiﬁcantly in-
creased by the presence of FMRP. We generated three
mutants, each one impairing the formation of the three stem
loops, respectively. All three mutants have a negative impact
on the translational effect of SoSLIP. In addition, the absence
of FMRP reduces the translational efﬁciency of the SL2 and
SL3 mutants. These ﬁndings suggest that when SL2 is mutated
the activities of SL1 and SL3 are probably still present, with
SL3 activity being abolished in the Fmr1 null cells. In a similar
way, when SL3 is mutated, the activities of SL1 and SL2 are
still observable in wild-type cells. These data are consistent
with the in vitro binding results, showing an interaction of
FMRP with the L2 and L3 loops, and with the ﬁnding that in
both mutants the FMRP/SoSLIP interaction is reduced but
not completely abolished. Interestingly enough, the SL1
mutation does not impair the binding of FMRP to SoSLIP
but blocks its activity as a translational enhancer. We propose
that the structural alteration due to the disruption of the SL1
stem prevents the conformational changes in SoSLIP struc-
ture upon interaction with FMRP that should promote
translational activation. In this case, even if FMRP can
recognize and bind SL2 and SL3 via the two loop structures,
its function is abolished. Alternatively, FMRP needs the
interaction with a factor(s) (probably binding to SL1) to carry
out its function as an enhancer of translation. Due to the
conformational changes of L2 and L3 stems induced by
FMRP, we therefore propose that FMRP would facilitate
ribosome scanning by participating in the remodelling of the
SoSLIP structure, promoting in particular the exposure of
the AUG of Sod1 mRNA. This function is possibly cooperating
with factor(s) binding the SL1 stem loop. Furthermore, our
data suggest that the mechanism of action of FMRP is
dependent on the type of RNA structure to which it binds.
FMRP binds both G-quartet and SoSLIP RNAs through its C-
terminal region containing the RGG box, even if in different
ion concentrations. For this reason, it is tempting to
speculate that in vivo the local ionic environment modulates
the RNA binding properties for FMRP and favors the binding
of either G-quartet or SoSLIP-containing mRNAs. This
possibility might be particularly relevant in the synaptic
compartment, because the binding of FMRP to its different
mRNA targets might be directly modulated by depolarization.
In conclusion, SoSLIP can be considered as a ‘‘bipartite’’
translational activator: one domain (SL2 and SL3) acts in an
FMRP-dependent-manner; the other (SL1) is independent of
the presence of the Fragile X protein. Moreover, we also
observed that SoSLIP may act as an IRES-like sequence. We
observe that FMRP does not promote and/or inﬂuence this
additional function of SoSLIP, suggesting that a speciﬁc
mechanism of translational regulation is probably activated
to translate SoSLIP-containing uncapped RNA. These data
conﬁrm the complexity of the translational regulation
mediated by SoSLIP, and further studies will be necessary
to fully understand its mechanism of action. Most important
for our study, in this context, the function of FMRP is
relevant to positively modulate SoSLIP-containing mRNA
synergizing with other factor(s).
Sod1 is a well-known protein with antioxidant properties.
Alterations of oxidative stress have been proposed to occur in
FMR1 null ﬂies, because changes in the expression of proteins
involved in redox reactions have been observed (1-cys
peroxiredoxin in brain and peroxiredoxin and thioredoxin
peroxidase in testis) [29,30], and a moderate increase of
oxidative stress in the brain of Fmr1 knockout mice has been
recently described [11]. This modest impact of the absence of
FMRP on brain oxidative stress might be due to the complex
regulation of Sod1 expression and the fact that the two FXR1P
isoforms most expressed in the brain (Isoa and Isod) are also
able to bind SoSLIP, even if with a lower afﬁnity if compared
with that of FMRP, suggesting that they can partially rescue
FMRP function in Fmr1 null cells. In addition, the FXR1P
muscular isoform (Isoe) could functionally replace FMRP in
muscle cells where this protein is absent. Moreover, mod-
iﬁcations of oxidative stress have been linked to anxiety [31],
sleep troubles [32], and autism [33], all phenotypic character-
istics displayed by Fragile X patients [34]. Interestingly,
chronic pharmacological treatment with a-tocopherol has
been reported to reverse behavior and learning deﬁcits of
Fmr1 knockout mice [35]. At the molecular level, Sod1 has
been indicated as a regulator of growth factor signaling. In
particular, Sod1 inhibition may attenuate phospho-extrac-
ellular signal-regulated kinase (pERK) signaling [12]. In this
sense, it is remarkable that the rapid activation of ERK1/2
after metabotropic glutamate receptor 1 (mGluR1) stimula-
tion is altered in Fmr1 null mice [36], suggesting that reduced
expression of Sod1 may contribute to this phenotype in Fmr1
null synapses. In conclusion, our study suggests a role for
Sod1 in the physiopathology of Fragile X syndrome and
proposes a new function and novel mechanism of action for
FMRP.
Materials and Methods
Plasmid constructs. Primer sequences used to amplify Sod1 and
FMR1 cDNAs are summarized in Table S1.
Mouse full-length Sod1 (BC002066) and two of its deletion
constructs (Sod1-mid region and Sod1–64/SoSLIP) were subcloned into
the pGEM-T vector (Promega), and the Sod1–39 UTR construct was
subcloned into the pCR2.1-TOPO vector (Invitrogen). SL1, SL2, and
SL3 mutants were generated starting from the Sod1–64 pGEM-T
vector and using the QuickChange site-directed mutagenesis kit
(Stratagene) and the oligonucleotides described in Table S1.
SoSLIP and its three mutants were cloned into the pcDNA3.1 zeo
vector (Invitrogen) (Luc) using Sod1–64/SoSLIP HindIII primers
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and SL3-Luc constructs.
Sequences coding for KH1, KH2, and FMRP C-terminal domains
were ampliﬁed by PCR from obtained FMR1 ISO7 cDNA [14] using
the appropriate primers. The PCR products were subcloned into the
pET 151/DTOPO vector (Invitrogen), and the constructs were veriﬁed
by sequencing.
For pPRIG-empty, the IRES sequence was removed by digestion of
pPRIG-HA-red [22] with SalI and HindIII, ﬁlling in with the Klenow
large fragment of DNA polymerase I and religation. SoSLI-PRIG was
obtained by replacing the IRES SalI-HindIII fragment of pPRIG-HA-
red with double-stranded oligonucleotides (Table S1) representing
the sequence of SoSLIP. All constructs were veriﬁed by DNA
sequencing.
Immunoblot analysis. Protein extraction and immunoblot analysis
were performed as previously described [5]. The antibodies used in
immunoblot analyses were used at the following concentrations: anti-
FMRP antibody 1C3 1:10,000 [5], rabbit polyclonal anti-Sod1 anti-
body (Sod-100) (Stressgen) 1:5,000, monoclonal anti b-tubulin (E7)
antibody (Iowa Hybridoma Bank) 1:5,000, and rabbit polyclonal anti-
L7a antibody (a gift from A. Ziemiecki) 1:40,000.
Protein expression. Recombinant protein expression and puriﬁ-
cation were performed as previously described [15]. In vitro
translated proteins (luciferase and Sod1) were produced using the
RRL/WGE combination system (Promega). The mRNAs translated in
these in vitro reactions were produced using T7 RNA polymerase
(Promega) and using the mMessage mMachine kit (Applied Bio-
systems) speciﬁc for the synthesis of cap-modiﬁed mRNA. In both
cases, we followed the manufacturer’s protocol by starting from
linearized plasmids (Luc, SoSLIP-Luc, and Sod1).
RNA binding assay. All RNAs were produced using T7 RNA
polymerase (Promega), according to the manufacturer’s protocol by
starting from linearized plasmids. The pGEM-T and pTL1 vectors
were linearized using PstI, and the pCR2.1 TOPO vector was
linearized with BamH1. The Sod1–59 region was obtained by digesting
pGEM-T Sod1 full-length with BstXI. Restriction enzymes were
purchased from New England Biolabs. RNAs were puriﬁed on
NucAway spin columns (Ambion), and their qualities were veriﬁed
on an polyacrylamide/urea gel after staining with Stains-All (Sigma).
Protein/RNA interactions were analyzed either by electromobility
shift assay or by ﬁlter binding assay, as previously described [4]. All of
the experiments have been repeated at least three times. All values
obtained are listed in Table S2.
Structure-forming RNA detection. The presence of a G-quartet
structure in the Sod1 mRNA was tested both by binding assay and by
RT with different primers along the Sod1 mRNA, as previously
described, in the presence of Na
þ or K
þ in both experiments [4]. For
the primer extension assays, RT was performed as described and
using the following c-
32ATP 39-end-labeled primers [4]:
Primer I 59-CTCTTCAGATTACAGTTT-39;p r i m e rI I5 9-
GTACGGCCAATGATGGAATG-39; primer III 59-GGATTAAAAT-
GAGGTCCTGC-39; primer IV 59-CTTCTGCTCGAAGTGGATG-39;
primer V 59-CTTCAGCACGCACGC-39.
The Sod1–64 RNA boundaries were determined as previously
described [4].
Cell cultures and transfections. Primary cultures of hippocampal
neurons were obtained from wild-type and FMR1 null mouse
embryos at 18 days of gestation. Primary cultures of cortical neurones
were grown into 24-well format plates in 500 ll of Neurobasal
Medium (Gibco) supplemented with 13 B27 (Gibco) and 0.5 mM L-
glutamine in the presence of 100 IU/ml penicillin/streptomycin at 37
8Ci n5 %C O 2. STEK FMR1 null cells and its derivative stably
transfected with FMR1 cDNA [5] were grown as previously described
[5]. Before transfection, cells were incubated in antibiotic-free
medium. For the luciferase assay, transfections were performed in
triplicate with Effectene (Invitrogen) as described by the manufac-
turer with 50 ng of the reporter gene (SoSLIP-ﬁreﬂy luciferase) and 5
ng of the plasmid coding for the Renilla luciferase used as a
normalizer for each well.
Luciferase assays. Assays were performed 12 h after transfection.
Starting from cell monolayers in 24-well cluster dishes, Renilla and
ﬁreﬂy luciferase activities were determined using the Dual-Luciferase
Reporter Assay System (Promega) and following the manufacturer’s
protocol. Luciferase activities were measured using a Luminoskan
Ascent luminometer. AUs of luciferase activity were calculated
accordingly the protocol of the luminometer manufacturer (Thermo
Labsystem). In each transfection, ﬁreﬂy luciferase values were
normalized with Renilla luciferase values.
Chemical and enzymatic probing of the Sod1–59 region to
determine the SoSLIP structure. The 59 UTR of Sod1 RNA (5 pmol)
was renatured at 40 8C for 15 min in the appropriate native buffer (50
mM Hepes buffer pH 7.5 for DMS or borate buffer pH 8 for CMCT, 5
mM Mg Acetate, 50 mM KOH acetate, and 2 mM b-mercaptoethanol).
Chemical modiﬁcations were performed in a ﬁnal volume of 20 ll
using either 1 ll of DMS diluted 1:2 (v/v) in ethanol or 60 lg of CMCT
(carbodiimide) at 20 8C for 5 and 15 min, respectively, and in the
presence of 2 lgo fEscherichia coli tRNA. Enzymatic modiﬁcations
were performed with V1 (0.0002 and 0.001 U), T1 (0.05 and 0.1 U),
and T2 (0.05 and 0.1 U) nucleases, followed by a phenol/chloroform
extraction. After ethanol precipitation and solubilization in the
appropriate buffer, modiﬁed RNAs were reverse-transcribed using
labeled primer III, and sequencing reactions and gel analysis were
carried out as previously described [16]. In the presence of FMRP,
experiments were performed using recombinant His-FMRP produced
in a bacterial system [15] and GST-FMRP produced in a baculovirus
system [4]. In the second case, protein was used attached to the
glutathione beads treated with bovine serum albumin (1 lg/ll ﬁnal
concentration). RNA was incubated with the same amount of
pretreated beads.
RT-PCR. The RT reactions were performed with 2 lg of RNA using
the ThermoScript RT-PCR system (Invitrogen). All mRNAs extracted
from transfected cells were treated with DNase I (4 U for each RT
reaction) for 1 h at 37 8C before RT. DNase was removed by phenol/
chloroform treatments, and the mRNA was recovered after ethanol
precipitation. The PCR reactions were carried out with the qPCR
Core kit for Syber Green I (Eurogentec) in an ABI PRISM 7000
instrument (Applied BioSystems). Primers used to amplify Sod1 and
the control Hprt are indicated in Table S1. Relative changes in mRNA
amounts were calculated based on the 2 DDCT method [37].
RNA stability. STEK cells and neurons cultured in vitro for 10 days
were treated with 5 lM actinomycin D (Sigma) for 2, 4, 6, and 12 h.
Total RNA was puriﬁed from actinomycin-treated cells using the
Qiagen RNeasy Mini Kit, and the RNA quality was veriﬁed on a 1%
agarose gel and by optical density (OD) measurement. The Sod1
mRNA level quantiﬁcation was performed with the 2 DDCT method
[37].
Polyribosome puriﬁcation. Polyribosome puriﬁcation and analysis
were performed following our previously described protocol [19]
with minor modiﬁcations. Brieﬂy, 1% Nonidet P-40 (NP-40) was
added to the postmitochondrial supernatant, and 7 ml of the solution
was layered over a 3-ml pad made of 45% sucrose in an 11-ml tube
and centrifuged in a Sorvall TH-641 rotor at 34,000 rpm for 3 h. The
ribosomal pellets were then resuspended in a buffer (20 mM Tris HCl,
pH 7.4, 100 mM KCl, 1.25 mM MgCl2, 0.5% NP40, 1 U/ml RNAsin).
Resuspended polyribosomes were analyzed by 15–45% sucrose
gradients composed of 25 mM Tris HCl, pH 7.4, 100 mM KCl, 5
mM MgCl2, and 1 U/ml RNAsin. After centrifugation in a Sorvall TH-
641 rotor for 2 h at 34,000 rpm and 4 8C, gradients were fractionated
by upward displacement using an ISCO UA-5 ﬂow-through spec-
trophotometer set at 254 nm and connected to a gradient collector.
Fifteen fractions of 800 ll each were collected from the sucrose
gradient. Approximately 100 ll of each fraction was ethanol-
precipitated, resuspended in 50 ll of Laemmli buffer, and analyzed
by immunoblot. The remaining 700 ll of each fraction was treated
with Trizol (Invitrogen) to purify RNA. The quality of RNA was
veriﬁed on a 1% agarose gel and by OD measurement. Three
independent polyribosomal puriﬁcations were carried out for brain
extracts and for STEK cell extracts.
FACS analysis. Cells were transfected for 48 h and after washing in
phosphate-buffered saline were analyzed with a FACScalibur instru-
ment (Becton Dickinson BD system). Cells expressing DsRed, with a
constant intensity, were selected, and the mean of the eGFP intensity
(expressed as AUs) of each sample was measured with the instrument
software. The experiment was repeated three times in HeLa cells,
COS cells, STEK cells expressing or not expressing FMRP, NG108
cells, and hippocampal primary neurons.
Supporting Information
Figure S1. Primer Extension Assay Used To Detect the Presence of a
G-Quartet Structure in the Sod1 mRNA
RT reactions were performed in the presence of 100 mM KCl or 100
mM NaCl, using the
32P- 59-end-labeled primer I that hybridizes at
positions þ486; þ464 (A), primer III (þ194;þ174) (B), or primer IV
(þ66;þ46) (C). The resulting cDNA was separated on an 8%
polyacrylamide/8 M urea sequencing gel and analyzed by auto-
radiography. RNA sequencing reactions were run in parallel. No
speciﬁc RT stops were detected in the presence of potassium ion, thus
excluding the presence of any G-quartet.
PLoS Biology | www.plosbiology.org January 2009 | Volume 7 | Issue 1 | e1000016 0143
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Figure S2. RNA Binding Properties of FMRP and FXR1P Isoforms
(A) Filter binding assay using FMRP and FXR1P Isoe, Isod, and Isoa.
The RNA probe used is
32P-labeled Sod1 RNA, and competition was
performed using the same unlabeled RNA.
(B) The same experiment was repeated using as a competitor the N8
RNA sequence, which we have previously shown [15] to be unable to
bind either FMRP or FXR1P isoforms.
Found at doi:10.1371/journal.pbio.1000016.sg002 (4.2 MB TIF).
Figure S3. Enzymatic (A) and Chemical (B) Probing of In Vitro
Transcribed Sod1–59 Region
Cleavage and modiﬁcation sites were detected by primer extension
using the
32P- 59-end-labeled primer IV. The resulting cDNA was
separated on an 8% polyacrylamide/8 M urea sequencing gel and
analyzed by autoradiography. RNA sequencing reactions were run in
parallel. The nature and positions of different loops and stems are
indicated at right. Increasing concentrations of RNase V1 (V1), RNase
T1 (T1) (right), or chemical agents (DMS or CMCT) (left) were added
before the reverse transcription step. The en-dash indicates the lanes
where the untreated RNA was loaded.
Found at doi:10.1371/journal.pbio.1000016.sg003 (4.5 MB TIF).
Figure S4. Stability of SoSLIP-Luc and Its Mutants in the Presence or
in the Absence of FMRP
(A) Cytoplasmic RNA was extracted from STEK cells expressing or
not expressing FMRP and transfected with Luc, SoSLIP-Luc, SL1-Luc,
SL2-Luc, and SL3-Luc, respectively. Luciferase mRNA levels were
analyzed by qRT-PCR and normalized to Hprt in each sample. As
shown in the diagram, luciferase mRNA levels were not affected by
the presence of SoSLIP or its mutants or by the presence or the
absence of FMRP. No statistically signiﬁcant differences have been
observed for luciferase mRNA levels obtained from different
constructs if compared with luciferase expressed from Luc. No
statistically signiﬁcant differences have been observed for luciferase
mRNA levels in tissues and cell lines expressing or not expressing
FMRP.
(B) STEK cells expressing FMRP were transfected with vectors Luc,
SoSLIP-Luc, SL1-Luc, SL2-Luc, and SL3-Luc. Twelve hours after
transfection, cells were incubated with 5 lM actinomycin D. Sod1
mRNA levels were quantiﬁed at different times (2, 4, 6, and 12 h) after
the treatment. Values obtained are shown in Table S2.
(C) Fmr1 null STEK cells were transfected with vectors Luc, SoSLIP-
Luc, SL1-Luc, SL2-Luc, and SL3-Luc. Twelve hours after transfection,
cells were incubated with 5 lM actinomycin D. Total RNA was
extracted, and Sod1 mRNA levels were quantiﬁed at different times (2,
4, 6, and 12 h) after the treatment. Values obtained are shown in
Table S2.
Found at doi:10.1371/journal.pbio.1000016.sg004 (6.2 MB TIF).
Table S1. Primer Sequences
Found at doi:10.1371/journal.pbio.1000016.st001 (27 KB PDF).
Table S2. List of Values Obtained in Experiments Described in
Figures 1, 2, 5, 7, and Figure S2
Found at doi:10.1371/journal.pbio.1000016.st002 (37 KB PDF).
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